Trials / Completed
CompletedNCT01658020
A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg
Clinical Trials to Evaluate Efficacy and Safety of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg After Multi-dose Oral Administration in Patients With Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 345 (actual)
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple dose of Zabofloxacin Tablet 400 mg.
Detailed description
A Phase 3, Multicenter, Double Blind, Active Controlled, Randomized Study to Evaluate the Efficacy and Safety of Zabofloxacin for Patients with acute bacterial exacerbation of Chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zabofloxacin | Zabofloxacin 367mg tablet P.O. once daily for 5days and then Placebo P.O. once daily for 2days |
| DRUG | Moxifloxacin | Moxifloxacin 400mg tablet P.O. once daily for 7days |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2014-01-01
- Completion
- 2014-08-01
- First posted
- 2012-08-06
- Last updated
- 2014-10-13
- Results posted
- 2014-09-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01658020. Inclusion in this directory is not an endorsement.